Scutellaria baicalensis

Scutellaria baicalensis is a traditional Chinese herb containing baicalein, baicalin, and wogonin as primary bioactive compounds. These flavonoids exert hepatoprotective, anti-inflammatory, and anticancer effects through multiple cellular pathways including NF-κB inhibition.

Origin & History

Scutellaria baicalensis (Chinese skullcap or Huangqin) is a perennial herb native to East Asia, particularly China, Korea, Japan, Russia, and Mongolia, belonging to the Lamiaceae family. The medicinal parts are primarily the dried roots, extracted via decoction, water extraction, or ethanol extraction for use in traditional Chinese medicine formulations.

Historical & Cultural Context

In Traditional Chinese Medicine, S. baicalensis (Huangqin) has been used for over 2,000 years to clear heat, dry dampness, and detoxify, treating conditions like fever, inflammation, and liver disorders. It features prominently in classic prescriptions like Huangqin Decoction, now used as adjunct therapy in modern TCM clinical practice.

Health Benefits

• Enhances liver cancer treatment when combined with TACE therapy (7 RCTs, 646 patients showed improved tumor response rates, RR=1.57, 95% CI: 1.30-1.90, p<0.00001) - Moderate evidence
• May reduce migraine symptoms based on observational data from Taiwan's National Health Insurance Database and supportive rat models - Preliminary evidence
• Protects against liver, kidney, and lung injury through anti-inflammatory pathways demonstrated in preclinical toxin protection studies - Preliminary evidence
• Induces tumor cell death and inhibits cancer progression via apoptosis and autophagy mechanisms in HCC models - Preliminary evidence
• Potentially benefits ulcerative colitis and depression based on review mentions, though specific trial details unavailable - Traditional evidence

How It Works

The primary bioactive compounds baicalein, baicalin, and wogonin inhibit nuclear factor-κB (NF-κB) signaling pathways, reducing inflammatory cytokine production. These flavonoids also modulate apoptosis through p53 activation and inhibit angiogenesis by blocking VEGF expression. Additionally, they enhance liver detoxification enzymes and provide antioxidant protection through Nrf2 pathway activation.

Scientific Research

Seven randomized controlled trials involving 646 hepatocellular carcinoma patients (ages 18-72) demonstrated that S. baicalensis combined with transarterial chemoembolization improved tumor response rates compared to controls alone. The meta-analysis (PMID: 38232757) showed significant benefits, though individual RCT PMIDs were not specified in the source.

Clinical Summary

Seven randomized controlled trials involving 646 liver cancer patients demonstrated that Scutellaria baicalensis combined with TACE therapy improved tumor response rates significantly (RR=1.57, 95% CI: 1.30-1.90, p<0.00001), representing moderate-quality evidence. Observational data from Taiwan's National Health Insurance Database suggests potential benefits for migraine symptom reduction, though this remains preliminary evidence. Most clinical research focuses on standardized extracts containing 85-95% total flavonoids. Additional studies are needed to establish optimal dosing protocols and long-term safety profiles.

Nutritional Profile

Scutellaria baicalensis (Chinese Skullcap root) is not consumed as a food source and lacks conventional macronutrient/caloric significance; its profile is defined primarily by its bioactive phytochemical constituents. Key flavonoids include baicalin (the predominant glycoside, typically 10–15% dry weight of root, up to 150 mg/g in standardized extracts), baicalein (aglycone form of baicalin, 1–5% dry weight, formed via hydrolysis by gut microbiota or during processing), wogonoside (glycoside, ~1–4% dry weight), and wogonin (aglycone, ~0.5–2% dry weight). Additional flavonoids present at lower concentrations include oroxylin A (~0.1–0.5%), scutellarein, and norwogonin. Bioavailability notes: baicalin undergoes extensive first-pass hydrolysis in the gut by bacterial β-glucuronidase to yield the more bioavailable aglycone baicalein; oral bioavailability of baicalin is low (~2–5%) but improved through this conversion; baicalein is absorbed more readily in the small intestine. Minor constituents include iridoids, sterols (β-sitosterol, ~trace levels), amino acids (proline, arginine at mg/g trace levels), polysaccharides (~5–10% dry weight contributing to immune-modulating activity), and small amounts of essential minerals including calcium (~4–8 mg/g), potassium (~3–6 mg/g), and magnesium (~1–3 mg/g) in raw root. Total phenolic content ranges from 80–200 mg GAE/g in dried root extracts. Fat-soluble compounds are minimal; no significant vitamins or dietary fiber in pharmacologically relevant quantities.

Preparation & Dosage

Clinical HCC trials used S. baicalensis in fixed TCM prescriptions like Huangqin Decoction without specified isolated dosages. Preclinical studies used oral dried S. baicalensis at 10 g/kg in rats, baicalin at 100-200 mg/kg/day orally, or baicalein at 5 μM in diet. Human dosage ranges for standardized extracts are not established in clinical trials. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Milk thistle, Curcumin, Green tea extract, Astragalus, Schisandra

Safety & Interactions

Scutellaria baicalensis is generally well-tolerated with mild gastrointestinal upset reported in some users. The herb may interact with cytochrome P450 enzymes, potentially affecting metabolism of certain medications including warfarin and cyclosporine. Due to limited safety data, pregnant and breastfeeding women should avoid use. Individuals with autoimmune conditions should exercise caution as the herb may modulate immune system activity.